Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma

Fig. 3

Comparison of EGFR mutations detected using clinical sequencing and targeted deep sequencing. a Mutation summary of clinical sequencing cohort (n = 64). b Incidence of concomitant EGFR uncommon mutations in patient with L858R (orange), exon 19 deletion (purple), and G719X (pink). Patients with single mutation (pale shaded) and compound mutation (solid with dot) were outlined

Back to article page